相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural analysis of the full-length human LRRK2
Alexander Myasnikov et al.
CELL (2021)
Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease
Matthew Taylor et al.
CURRENT OPINION IN CELL BIOLOGY (2020)
Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2
Jascha T. Manschwetus et al.
FRONTIERS IN NEUROSCIENCE (2020)
The In Situ Structure of Parkinson's Disease-Linked LRRK2
Reika Watanabe et al.
CELL (2020)
Structure of LRRK2 in Parkinson's disease and model for microtubule interaction
C. K. Deniston et al.
NATURE (2020)
Parkinson's disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics
Chun-Xiang Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Interactive Peptide Spectral Annotator: A Versatile Web-based Tool for Proteomic Applications
Dain R. Brademan et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain
Sven H. Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits
Antonio Jesus Lara Ordonez et al.
HUMAN MOLECULAR GENETICS (2019)
Structure, Function, Involvement in Diseases and Targeting of 14-3-3 Proteins: An Update
Ylenia Cau et al.
CURRENT MEDICINAL CHEMISTRY (2018)
LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages
Anetta Hartlova et al.
EMBO JOURNAL (2018)
LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
Tomoya Eguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain
Herschel S. Dhekne et al.
ELIFE (2018)
Rab29 activation of the Parkinson's disease-associated LRRK2 kinase
Elena Purlyte et al.
EMBO JOURNAL (2018)
Nrf2 mitigates LRRK2-and α-synuclein-induced neurodegeneration by modulating proteostasis
Gaia Skibinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway
Alena Salasova et al.
MOLECULAR NEURODEGENERATION (2017)
Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis
Martin Steger et al.
ELIFE (2017)
Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
Kushal Sejwal et al.
SCIENTIFIC REPORTS (2017)
The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2
Iakov N. Rudenko et al.
BIOCHEMICAL JOURNAL (2017)
SnapShot: Expanding the Ubiquitin Code
Krishnaraj Rajalingam et al.
CELL (2016)
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1
Frederick C. Nucifora et al.
NATURE COMMUNICATIONS (2016)
The X-Linked-Intellectual-Disability-Associated Ubiquitin Ligase Mid2 Interacts with Astrin and Regulates Astrin Levels to Promote Cell Division
Ankur A. Gholkar et al.
CELL REPORTS (2016)
Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation
Max A. Horlbeck et al.
ELIFE (2016)
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger et al.
ELIFE (2016)
Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
E. Lobbestael et al.
SCIENTIFIC REPORTS (2016)
LRRK2 dephosphorylation increases its ubiquitination
Jing Zhao et al.
BIOCHEMICAL JOURNAL (2015)
MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments
Meena Choi et al.
BIOINFORMATICS (2014)
Targeted Deep Resequencing Identifies MID2 Mutation for X-Linked Intellectual Disability with Varied Disease Severity in a Large Kindred from India
Thenral S. Geetha et al.
HUMAN MUTATION (2014)
A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific β-Tubulin Isoforms Regulates Tubulin Acetylation
Bernard M. H. Law et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct celluar signaling pathways
Lauran Reyniers et al.
JOURNAL OF NEUROCHEMISTRY (2014)
CLASPs link focal-adhesion-associated microtubule capture to localized exocytosis and adhesion site turnover
Samantha J. Stehbens et al.
NATURE CELL BIOLOGY (2014)
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
Sami J. Barmada et al.
NATURE CHEMICAL BIOLOGY (2014)
Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3
Kathrin Muda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Parkinson disease-associated mutation R1441H in LRRK2 prolongs the active state of its GTPase domain
Jingling Liao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
Alexandria Beilina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations
Vinay K. Godena et al.
NATURE COMMUNICATIONS (2014)
Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies
Paul Davies et al.
BIOCHEMICAL JOURNAL (2013)
Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration
Andrey S. Tsvetkov et al.
NATURE CHEMICAL BIOLOGY (2013)
Interplay of LRRK2 with chaperone-mediated autophagy
Samantha J. Orenstein et al.
NATURE NEUROSCIENCE (2013)
CRISPR interference (CRISPRi) for sequence-specific control of gene expression
Matthew H. Larson et al.
NATURE PROTOCOLS (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration
Mareike Caesar et al.
NEUROBIOLOGY OF DISEASE (2013)
LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization
Rossana Migheli et al.
PLOS ONE (2013)
The role of LRRK2 in inflammatory bowel disease
Zhihua Liu et al.
CELL RESEARCH (2012)
LRRK2 Parkinson disease mutations enhance its microtubule association
Lauren R. Kett et al.
HUMAN MOLECULAR GENETICS (2012)
Global landscape of HIV-human protein complexes
Stefanie Jaeger et al.
NATURE (2012)
Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Genetics of Parkinson's Disease
Christine Klein et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Zhihua Liu et al.
NATURE IMMUNOLOGY (2011)
Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
Xianting Li et al.
PLOS ONE (2011)
14-3-3 proteins are promising LRRK2 interactors
Iakov N. Rudenko et al.
BIOCHEMICAL JOURNAL (2010)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2010)
TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies
Kunikazu Tanji et al.
NEUROBIOLOGY OF DISEASE (2010)
LRRK2 in Parkinson's disease: genetic and clinical studies from patients
Udhaya Kumari et al.
FEBS JOURNAL (2009)
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model
Javier Alegre-Abarrategui et al.
HUMAN MOLECULAR GENETICS (2009)
Genomewide Association Study of Leprosy
Fu-Ren Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Regulation of LRRK2 Stability by the E3 Ubiquitin Ligase CHIP
Xiaodong Ding et al.
PLOS ONE (2009)
CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity
Han Seok Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells
Ricardo Rajsbaum et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation
Elisa Greggio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
Edward D. Plowey et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules
Payal N. Gandhi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
The familial parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al.
NEURON (2006)
Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding
KM Short et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Assessment of PC12 cell differentiation and neuritc growth: a comparison of morphological and neurochemical measures
KP Das et al.
NEUROTOXICOLOGY AND TERATOLOGY (2004)
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
L Petrucelli et al.
HUMAN MOLECULAR GENETICS (2004)
Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp red fluorescent protein
NC Shaner et al.
NATURE BIOTECHNOLOGY (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families
N Pankratz et al.
HUMAN MOLECULAR GENETICS (2003)
MID1 and MID2 homo- and hetero-dimerise to tether the rapamycin-sensitive PP2A regulatory subunit, Alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders
KM Short et al.
BMC CELL BIOLOGY (2002)
MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation
A Trockenbacher et al.
NATURE GENETICS (2001)
分享论文
